Retail Trade and Distribution

• China Issues Data Protection Measures for the Healthcare and Medical Industry

  Vivian Wu, counsel, and Xuan He, associate at FenXun Partners, in Beijing discuss the new rule issued by China's National Health Commission regulating the administration of data protection in the healthcare and medical industry

  September 26, 2018

  

• CFIUS Law Reform Imposes Serious Threats to Chinese Investments in the US

  Aaron Cutler, partner at Hogan Lovells, Washington, D.C. speaks to China Law & Practice on the new rules of the Committee on Foreign Investment in the United States (CFIUS) and its potential impact on Chinese investments in the U.S. Lawyers and in-house counsel should potentially understand the stricter controls imposed as the Foreign Investment Risk Review Modernization Act (FIRRMA) will significantly increase the number of transactions subject toCFIUS' review

  September 19, 2018

  

• Special Administrative Measures for Foreign Investment Access (Negative List) (2018 Edition)

  外商投资准入特别管理措施 (负面清单) (2018年版)

  The national negative list is relaxed

  September 10, 2018

• Special Administrative Measures for Foreign Investment Access in Pilot Free Trade Zones (Negative List) (2018 Edition)

  自由贸易试验区外商投资准入特别管理措施 (负面清单) (2018年版)

  The 2018 version of the FTZ Negative List greatly relaxes market access

  September 10, 2018

• National Development and Reform Commission and Ministry of Commerce, Special Administrative Measures for Foreign Investment Access in Pilot Free Trade Zones (Negative List) (2018 Edition)

  国家发展和改革委员会、商务部自由贸易试验区外商投资准入特别管理措施 (负面清单) (2018年版)

  The 2018 version of the FTZ Negative List greatly relaxes market access

  September 08, 2018

• National Development and Reform Commission and Ministry of Commerce, Special Administrative Measures for Foreign Investment Access (Negative List) (2018 Edition)

  国家发展和改革委员会、商务部外商投资准入特别管理措施 (负面清单) (2018年版)

  The national negative list is relaxed

  September 08, 2018

• Exciting Times Ahead for Trade Lawyers Amidst US-China Trade War

  William Marshall of Tiang & Co speaks to Jacelyn Johnson about the exciting times of being a trade lawyer amidst a burgeoning trade war between US and China, the impact of tariffs, and what lawyers should expect and be mindful of when negotiating or advising on export and import matters, foreign investments, tax and customs regulations and other trade related issues when dealing with China.

  August 30, 2018

  

• Rising Above the Fake to Keep It Real

  Justina Zhang, Senior Partner of Beijing's TransAsia Lawyers discusses the risks and liabilities faced by e-commerce platform providers and safeguard measures that can be employed to protect against potential infringement disputes from third-party sale of counterfeit goods on their platforms.

  August 29, 2018

  

• China's Proposed Export Control Law—a Major New Weapon in the Sino-US Trade Dispute

  William Marshall of Tiang & Co analyzes the proposed Export Control Law and China's competitive advantage over the US, especially in relation to technology, should this legislation come into force.

  August 23, 2018

  

• Official Reply on Matters Relevant to the Production and Distribution of Pharmaceuticals in the Pilot Marketing Authorization Holder Project

  关于药品上市许可持有人试点工作药品生产流通有关事宜的批复

  MAHs may entrust the sale of pharmaceuticals

  August 08, 2018